These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35656441)

  • 1. MAGI2-AS3 restrains proliferation, glycolysis, and triggers apoptosis in acute lymphoblastic leukemia via regulating miR-452-5p/FOXN3 pathway.
    Chen XG; Dou BH; An JD; Feng S; Liu N; Sheng GY
    Iran J Basic Med Sci; 2022 Jan; 25(1):46-52. PubMed ID: 35656441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.
    He J; Zhou X; Li L; Han Z
    Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
    Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
    J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
    Cao C; Zhou S; Hu J
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
    Gong J; Ma L; Peng C; Liu J
    Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MAGI2
    Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z
    J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis.
    Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B
    Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
    Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
    Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3.
    Xu Z; Chen Z; Peng M; Zhang Z; Luo W; Shi R; Wang L; Hong Y
    Bioengineered; 2022 Feb; 13(2):2673-2685. PubMed ID: 35043728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
    Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
    Ren H; Li Z; Tang Z; Li J; Lang X
    J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
    Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA
    ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
    Chang H; Zhang X; Li B; Meng X
    Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b.
    Chai Y; Wang L; Qu Y; Hu Z
    J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis.
    Wei H; Tang Q; Wang A; Zhang Y; Qin Z; Li W; Xu Z; Wang J; Pu J
    J Oncol; 2021; 2021():5547345. PubMed ID: 34484334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
    Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
    J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
    Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
    Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MAGI2-AS3 in malignant and non-malignant disorders.
    Taheri M; Askari A; Hussen BM; Ghafouri-Fard S; Rashnoo F
    Pathol Res Pract; 2023 Jun; 246():154530. PubMed ID: 37196468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
    Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
    Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.